Urology and Nephrology Center
Al Mansurah, 35516, Egypt
NCT Number: NCT06101563
This study will be conducted to compare early (seven days) versus delayed (14-21 days) definitive ureteroscopic lithotripsy after initial drainage for obstructing ureteral or renal stones associated with infection.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Al Mansurah, 35516, Egypt
All the study participants will be monitored during the early post-operative period for post-operative pain and complications. The rate and grade of reported complications will be determined according to modified Dindo-Clavian grading system. After ensuring safe status for discharge, all patients will be reassessed at the outpatient department after 4 weeks by NCCT to assess stone free status.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be managed by ureteroscopic lithotripsy 7 days after drainage.
Patients will be managed by ureteroscopic lithotripsy 14-21 days after drainage.
Time frame: 30 days
Difference in post-URS infectious complications between the study groups. infectious complications are defined as presence of urinary tract infection with one of the following findings: - Body temperature more than 38.3C or below 36C. - Tachycardia (>90/minute). - Respiratory rate more than 20/minute. - Disturbed mental status. - Systolic blood pressure < 90 mmHg & mean arterial pressure < 70 mmHg or systolic blood pressure decrease < 40 mmHg. - WBC >12,000 or <4,000.
Mansoura University
Other
Optimal Duration Between Drainage for Obstructing Renal or Ureteral Stones Associated With Infection and Ureteroscopic Lithotripsy: A Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06110247
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT05725226
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Kathmandu, Bagmati, Nepal
View Trial DetailsNCT06412900
Calculi, Female Urogenital Diseases
Oslo, Norway
View Trial DetailsNCT06147817
Childhood, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial Details